|
1
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal Cancer: Molecular landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He R, Hu Z, Wang Q, Luo W, Li J, Duan L,
Zhu YS and Luo DX: The role of long non-coding RNAs in
nasopharyngeal carcinoma: As systemic review. Oncotarget.
8:16075–16083. 2017.PubMed/NCBI
|
|
3
|
Lee AW, Poon YF, Foo W, Law SC, Cheung FK,
Chan DK, Tung SY, Thaw M and Ho JH: Retrospective analysis of 5037
patients with nasopharyngeal carcinoma treated during 1976–1985:
Overall survival and patterns of failure. Int J Radiat Oncol Biol
Phys. 23:261–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spence T, Bruce J, Yip KW and Liu FF:
MicroRNAs in nasopharyngeal carcinoma. Chin Clin Oncol. 5:172016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee KT, Tan JK, Lam AK and Gan SY:
MicroRNAs serving as potential biomarkers and therapeutic targets
in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol
Hematol. 103:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:2018. View Article : Google Scholar
|
|
7
|
Zhao J, Li L, Wang Q, Han H, Zhan Q and Xu
M: CircRNA expression profile in early-stage lung adenocarcinoma
patients. Cell Physiol Biochem. 44:2138–2146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su H, Lin F, Deng X, Shen L, Fang Y, Fei
Z, Zhao L, Zhang X, Pan H, Xie D, et al: Profiling and
bioinformatics analyses reveal differential circular RNA expression
in radioresistant esophageal cancer cells. J Transl Med.
14:2252016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie Y, Shao Y, Sun W, Ye G, Zhang X, Xiao
B and Guo J: Downregulated expression of hsa_circ_0074362 in
gastric cancer and its potential diagnostic values. Biomark Med.
12:11–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patop IL and Kadener S: circRNAs in
Cancer. Curr Opin Genet Dev. 48:121–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okholm T, Nielsen MM, Hamilton MP,
Christensen LL, Vang S, Hedegaard J, Hansen TB, Kjems J, Dyrskjøt L
and Pedersen JS: Circular RNA expression is abundant and correlated
to aggressiveness in early-stage bladder cancer. NPJ Genom Med.
2:362017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei C, Wu S, Li X, Wang Y, Ren R, Lai Y
and Ye J: High expression of FER tyrosine kinase predicts poor
prognosis in clear cell renal cell carcinoma. Oncol Lett.
5:473–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han YN, Xia SQ, Zhang YY, Zheng JH and Li
W: Circular RNAs: A novel type of biomarker and genetic tools in
cancer. Oncotarget. 8:64551–64563. 2017.PubMed/NCBI
|
|
17
|
Zhang Y, Liang W, Zhang P, Chen J, Qian H,
Zhang X and Xu W: Circular RNAs: Emerging cancer biomarkers and
targets. J Exp Clin Cancer Res. 36:1522017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo YH, Zhu XZ, Huang KW, Zhang Q, Fan YX,
Yan PW and Wen J: Emerging roles of circular RNA hsa_circ_0000064
in the proliferation and metastasis of lung cancer. Biomed
Pharmacother. 96:892–898. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin WB, Yan MG, Fang X, Guo JJ, Xiong W
and Zhang RP: Circulating circular RNA hsa_circ_0001785 acts as a
diagnostic biomarker for breast cancer detection. Clin Chim Acta.
Oct 16–2017.(Epub ahead of print). View Article : Google Scholar
|
|
20
|
Chen G, Shi Y, Zhang Y and Sun J:
CircRNA_100782 regulates pancreatic carcinoma proliferation through
the IL6-STAT3 pathway. Onco Targets Ther. 10:5783–5794. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Yang L, Li JJ and Sun L:
Potential use of nucleic acid-based agents in the sensitization of
nasopharyngeal carcinoma to radiotherapy. Cancer Lett. 323:1–10.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen W and Hu GH: Biomarkers for enhancing
the radiosensitivity of nasopharyngeal carcinoma. Cancer Biol Med.
12:23–32. 2015.PubMed/NCBI
|
|
23
|
Ni J, Bucci J, Chang L, Malouf D, Graham P
and Li Y: Targeting MicroRNAs in prostate cancer radiotherapy.
Theranostics. 7:3243–3259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu X, Jiang H and Jiang X: Downregulation
of lncRNA ANRIL inhibits proliferation, induces apoptosis, and
enhances radiosensitivity in nasopharyngeal carcinoma cells through
regulating miR-125a. Cancer Biol Ther. 18:331–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang S, Pan Y, Zhang R, Xu T, Wu W, Zhang
R, Wang C, Huang H, Calin CA, Yang H and Claret FX: Hsa-miR-24-3p
increases nasopharyngeal carcinoma radiosensitivity by targeting
both the 3′UTR and 5′UTR of Jab1/CSN5. Oncogene. 35:6096–6108.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu H, Wang G and Li C: miR-124 suppresses
proliferation and invasion of nasopharyngeal carcinoma cells
through the Wnt/b-catenin signaling pathway by targeting Capn4.
Onco Targets Ther. 10:2711–2720. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu S, Zhao N, Hui L, Song M, Miao ZW and
Jiang XJ: MicroRNA-124-3p inhibits the growth and metastasis of
nasopharyngeal carcinoma cells by targeting STAT3. Oncol Rep.
35:1385–1394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: MiR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Shi Y, Liu M and Sun J: circHIPK3
regulates cell proliferation and migration by sponging miR-124 and
regulating AQP3 expression in hepatocellular carcinoma. Cell Death
Dis. 9:1752018. View Article : Google Scholar : PubMed/NCBI
|
